The FoundationOne CDx (F1CDx) is a diagnostic test that can detect gene mutations for cancer, and its potential to help patients has spurred the Centers for Medicare & Medicaid Services to pay for qualifying beneficiaries to be screened.
An immediate jeopardy deficiency can cost providers dearly in finances and reputation. But what if it’s not true? Legal expert Alan C. Horowitz discusses a recent case where the provider challenged CMS over nearly $1 million in fines—and won.
The criminal investigation into the eight South Florida nursing home deaths following Hurricane Irma is prompting a larger look at how long-term care facilities prepare—and practice—for natural disasters.